It has been a half-century since Neil Armstrong stepped out of a lunar module and onto the surface of the moon on July 20, 1969 and declared, "That's one small step for [a] man, one giant leap for mankind." The moment heralded a golden age of space exploration that was set in motion just eight years earlier in 1961, when United States President John F Kennedy promised before Congress to put a man on the moon before the decade was out. Here are some lesser-known facts about the historic first mission:
Financials were the top losers while oil shares also declined amid weak crude oil prices.
Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency
The deal would involve Pfizer paying with 11.3 of its shares for each Allergan share.
On the morning of February 15, ISRO will hurl into space using the Polar Satellite Launch Vehicle three Indian satellites and 101 small foreign satellites. No other country has ever tried to hit a century in a single mission.
India will boldly go to Venus for the first time and re-visit the Red Planet very soon.
BSE Midcap and Smallcap indices ended in line with their larger counterparts and closed marginally up 0.2% and 0.4%, each
The Society of Asian American Scientists in Cancer Research last month presented awards to seven doctors for their outstanding contributions to cancer research. The awards were presented by Rajvir Dahiya, SAASCR president, San Diego, California on April 6.
The 30-share Sensex is up 253 points at 29,263 and the 50-share Nifty has gained 68 points at 8,829.
Two skyscrapers were decimated the day 2,996 died, one and a half decades ago. George Joseph profiles the monument that has replaced them.
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
The 30-share Sensex ended down 30.30 points at 28,161.72 and the 50-share Nifty dipped 7.95 points at 8,543.
Engineering major BHEL rebounded from its day's lows to end around 1% higher.
Impact of the slowdown is most visible among promoter/owner-CEOs
Dr P K Menon, Chief Scientist and CEO, Optimal Synthesis Inc, who worked with Dr A P J Abdul Kalam early on in his career, recalls what it was like working for his first boss.
